25 May 2013
Keywords: genta, g3139, moves, into, ph, iii, melanoma
Article | 21 July 2000
US Oncology, a company which represents health care professionals inthe cancer field, has initiated a pivotal trial of Genta's G3139, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 2000
24 May 2013
© 2013 thepharmaletter.com